Platelet function profile post-clopidogrel therapy in patients with type 2 diabetes undergoing coronary stent implantation.

about

Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis

P2860

Q59100784-B798CE1E-6809-40B1-9029-0609CE26702E

P2860

Platelet function profile post-clopidogrel therapy in patients with type 2 diabetes undergoing coronary stent implantation.

Item

http://www.wikidata.org/entity/Q46358660

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Platelet function profile post ...... g coronary stent implantation.

@en

Platelet function profile post ...... g coronary stent implantation.

@nl

type

Item

label

Platelet function profile post ...... g coronary stent implantation.

@en

Platelet function profile post ...... g coronary stent implantation.

@nl

prefLabel

Platelet function profile post ...... g coronary stent implantation.

@en

Platelet function profile post ...... g coronary stent implantation.

@nl

P1476

Platelet function profile post ...... g coronary stent implantation.

@en

P2093

Abdel Rahman Hassan

http://www.w3.org/2001/XMLSchema#string

Abeer Attia Saad

http://www.w3.org/2001/XMLSchema#string

Eman Abdel Rahman Ismail

http://www.w3.org/2001/XMLSchema#string

Hesham Ahmed Nasr

http://www.w3.org/2001/XMLSchema#string

Ibrahim Bedeer

http://www.w3.org/2001/XMLSchema#string

Marian Adel Alfons

http://www.w3.org/2001/XMLSchema#string

Yasser Wagih Darwish

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the platelet ADP receptor targeted by antithrombotic drugs

Central role of the P2Y12 receptor in platelet activation

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance

Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

Clopidogrel resistance: a new chapter in a fast-moving story

Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting

Monitoring of clopidogrel action: comparison of methods

Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial

P304

249-257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1076029611427899

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22146578

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

clopidogrel

Platelet function profile post-clopidogrel therapy in patients with type 2 diabetes undergoing coronary stent implantation.

about

P2860

P2860

Platelet function profile post-clopidogrel therapy in patients with type 2 diabetes undergoing coronary stent implantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921